As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio spans more than 115 countries.
We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye.
Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept — taking pride in delivering innovative solutions for our physicians and patients, based on their needs.
We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.
We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye.
Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept — taking pride in delivering innovative solutions for our physicians and patients, based on their needs.
We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.
Location: United States, Massachusetts, Waltham
Employees: 1001-5000
Phone: (866) 906-8080
Total raised: $1B
Founded date: 1932
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.03.2025 | - | $1B | - |
Mentions in press and media 9
| Date | Title | Description |
| 13.03.2025 | BVI Medical: $1 Billion Strategic Capital Raised | BVI Medical, a leading global ophthalmic device company at the forefront of advancements in eye surgery, announced the completion of a $1 billion strategic capital raise in partnership with TPG. This investment, which fully refinances BVI’s... |
| 12.03.2025 | The Evolving Landscape of Investment and Innovation in 2025 | In the world of finance, change is the only constant. As we step into 2025, two significant players have emerged, showcasing the dynamic interplay between traditional investment strategies and the burgeoning cryptocurrency sector. Pamlico C... |
| 10.03.2025 | Pamlico Capital Closes Sixth Fund, at $1.75 Billion | Pamlico Capital, a Charlotte, NC-based middle-market private equity firm, closed Pamlico Capital VI, at $1.75 Billion. Fund VI received support from a diverse group of limited partners, including leading endowments, foundations, insurance c... |
| 10.03.2025 | BVI Medical Completes $1 Billion Strategic Capital Raise | BVI Medical, a Waltham, MA-based global ophthalmic device company, completed a $1 Billion in strategic capital raise in partnership with TPG. This investment, which fully refinances BVI’s existing debt and adds new equity from both TPG and ... |
| 31.01.2025 | BVI Medical Launches Educational Platform for Ophthalmology Professionals | BVI Medical Logo EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases. WALTHAM, Mass., Jan. 31, 2025 /PRNewswire-PR... |
| 08.09.2020 | BVI® expands Malosa® single-use instrument range in the US | |
| 17.08.2020 | BVI launches its first intraocular lens in the US; expands US portfolio with IPure®, a fully pre-loaded aspheric monofocal IOL | |
| 20.12.2018 | TPG Capital Backs BVI to Acquire PhysIOL Group | BVI (Beaver-Visitec International), a developer, manufacturer, and marketer of specialized surgical devices and custom procedure packs for the ophthalmic marketplace, signed a definitive agreement to acquire PhysIOL Group SA, a Belgium-base... |
| - | BVI Medical | “BVI® is a global medical company manufacturing and distributing surgical devices dedicated to ophthalmology in more than 90 countries.” |